ID
43651
Beschrijving
Predicting Response to Capecitabine in Women With Metastatic Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00953537
Link
https://clinicaltrials.gov/show/NCT00953537
Trefwoorden
Versies (2)
- 27-10-17 27-10-17 -
- 20-09-21 20-09-21 -
Houder van rechten
See clinicaltrials.gov
Geüploaded op
20 september 2021
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Breast Cancer NCT00953537
Eligibility Breast Cancer NCT00953537
- StudyEvent: Eligibility
Similar models
Eligibility Breast Cancer NCT00953537
- StudyEvent: Eligibility
C1513040 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
C2986546 (UMLS CUI [2,1])
C1516986 (UMLS CUI [2,2])
C1265611 (UMLS CUI [2,3])
C2363719 (UMLS CUI [2,1])
C1521840 (UMLS CUI [2,2])
C0796392 (UMLS CUI [3])
C0728747 (UMLS CUI [4])
C0220650 (UMLS CUI [2,1])
C0205318 (UMLS CUI [2,2])
C0449438 (UMLS CUI [1,2])
C0205370 (UMLS CUI [1,3])
C0205370 (UMLS CUI [1,2])
C0700589 (UMLS CUI [1,2])
C0008679 (UMLS CUI [2,1])
C0205318 (UMLS CUI [2,2])
C0018802 (UMLS CUI [2])
C0750166 (UMLS CUI [2])
C0009450 (UMLS CUI [2,1])
C0205318 (UMLS CUI [2,2])
C0205082 (UMLS CUI [2,3])
C0340194 (UMLS CUI [2])
C1306459 (UMLS CUI [2])
C1705847 (UMLS CUI [3,1])
C0007117 (UMLS CUI [3,2])
C0004936 (UMLS CUI [2])
C0671970 (UMLS CUI [2,1])
C0332281 (UMLS CUI [2,2])
C0392920 (UMLS CUI [2,3])